Phathom Pharmaceuticals, Inc. (PHAT)
11.14
+0.03
(+0.27%)
USD |
NASDAQ |
Apr 01, 16:00
10.80
-0.34
(-3.05%)
Pre-Market: 08:36
Phathom Pharmaceuticals Research and Development Expense (TTM) : 32.78M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Replimune Group, Inc. | 222.70M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| MannKind Corp. | 66.35M |
| Ocugen, Inc. | 37.87M |
| Vanda Pharmaceuticals, Inc. | 109.27M |